Hansen, J B <br/><br/>
Differential effects of low molecular weight heparin and unfractionated heparin on circulating levels of antithrombin and tissue factor pathway inhibitor (TFPI): a possible mechanism for difference in therapeutic efficacy.  [electronic resource] 

 -  Thrombosis research  Aug 1998 
 - 177-81 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0049-3848 
<br/><br/><label>Standard No.: </label>10.1016/s0049-3848(98)00079-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Cutaneous<br/>Adult<br/>Anticoagulants--administration & dosage<br/>Antithrombins--metabolism<br/>Heparin--administration & dosage<br/>Heparin, Low-Molecular-Weight--administration & dosage<br/>Humans<br/>Infusions, Intravenous<br/>Lipoproteins--blood<br/>Male<br/>Protein C--metabolism